Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cancer Pain × Cannabidiol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Anxiety Disorders 2 Sturge-Weber Syndrome 1 Solid Tumor 1 Parasomnias 1 Pain 1 Nausea 1 Marijuana Abuse 1 Glioblastoma 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Carcinoma In Situ 1 Arthralgia 1

Interventions

Morphine 2 resiniferatoxin 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 Surveys and Questionnaires 1 Standard of Care 1 Pain Management 1 Oxycodone 1 Massage 1 Lidocaine 1 Lenalidomide 1 Ketamine 1 Gels 1 Fentanyl 1 Dronabinol 1 Cannabidiol 1 Animal Assisted Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-03-12

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Active not recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡